<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04753736</url>
  </required_header>
  <id_info>
    <org_study_id>Immunophenotypage RIF and RM</org_study_id>
    <nct_id>NCT04753736</nct_id>
  </id_info>
  <brief_title>Immunophenotypage of RIF and RM Patients and Intrauterine Administration of PBMC</brief_title>
  <official_title>Intrauterine Administration and Immunophenotyping of Autologous Peripheral Blood Mononuclear Cells in Patients With Repeated Implantation Failures During Undergoing in Vitro Fertilization Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fertilys</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre hospitalier de l'Université de Montréal (CHUM)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fertilys</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to identify a systemic immunological profile specific to&#xD;
      patients with recurrent implantation failures (RIF) or miscarriages (RM) through blood&#xD;
      immunophenotyping on the day of ovulation. This study also aims to determine whether the&#xD;
      intrauterine administration of 5 million peripheral blood monocluear cells increases&#xD;
      implantation and pregnancy rates in patients with RIF and decreases the risk of miscarriages&#xD;
      in patients with RM, compared to what has already been published in the scientific literature&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2021</start_date>
  <completion_date type="Anticipated">February 2025</completion_date>
  <primary_completion_date type="Anticipated">June 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Embryo implantation rate (biochemical pregnancy)</measure>
    <time_frame>Two weeks following embryo transfer or 3 weeks following intrauterine insemination</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical pregnancy rate</measure>
    <time_frame>Six to 8 weeks of gestation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Peripheral blood mononuclear cells populations (PBMC) distribution at Day 0</measure>
    <time_frame>The day 0 of the patient's ovulation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peripheral blood mononuclear cells populations distribution at Day 2</measure>
    <time_frame>After 48 hours of culture</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cytokines (LIF, IL-6, IL-10, TNFα, FGF-2, VEGF, IL-8) quantification by ELISA in PBMC culture medium at Day 2</measure>
    <time_frame>After 48 hours of culture</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Infertility, Female</condition>
  <arm_group>
    <arm_group_label>No recurrent implantation failure</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Recurrent implantation failures</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Recurrent miscarriage</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intrauterine administration of hCG-activated peripheral blood mononuclear cells</intervention_name>
    <description>Intrauterine administration of hCG-activated peripheral blood mononuclear cells</description>
    <arm_group_label>Recurrent implantation failures</arm_group_label>
    <arm_group_label>Recurrent miscarriage</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All women aged 18 and over undergoing an IVF cycle with her partner's sperm at the&#xD;
             Fertilys fertility center, without a RIF status, agreeing to participate in the study&#xD;
             and having signed the consent form to participate in the study.&#xD;
&#xD;
          -  All women aged 18 and over undergoing an IVF cycle with her partner's sperm at the&#xD;
             Fertilys fertility center, with a RIF or RM status, agreeing to participate in the&#xD;
             study and having signed the consent form to participate in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women who need a gametes donor (eggs and / or sperm).&#xD;
&#xD;
          -  Women undergoing an IVF cycle with frozen sperm.&#xD;
&#xD;
          -  Women with autoimmune disease.&#xD;
&#xD;
          -  Women with diabetes.&#xD;
&#xD;
          -  Women with a history of chemotherapy treatment.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fabien Joao, M.Sc</last_name>
    <phone>4509349146</phone>
    <phone_ext>218</phone_ext>
    <email>fabien.joao@fertilys.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cyntia Duval, PhD</last_name>
    <phone>4509349146</phone>
    <phone_ext>218</phone_ext>
    <email>cyntia.duval@fertilys.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fertilys</name>
      <address>
        <city>Laval</city>
        <state>Quebec</state>
        <zip>H7S1Z5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Fabien Joao, M.Sc</last_name>
      <phone>4509349146</phone>
      <phone_ext>218</phone_ext>
      <email>fabien.joao@fertilys.org</email>
    </contact>
    <contact_backup>
      <last_name>Cyntia Duval, PhD</last_name>
      <phone>4509349146</phone>
      <phone_ext>218</phone_ext>
      <email>cyntia.duval@fertilys.org</email>
    </contact_backup>
    <investigator>
      <last_name>Marie-Claire Bélanger, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>February 11, 2021</study_first_submitted>
  <study_first_submitted_qc>February 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2021</study_first_posted>
  <last_update_submitted>August 18, 2021</last_update_submitted>
  <last_update_submitted_qc>August 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

